Salvatore Alfieri

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (10)

Lisa Licitra

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Nicola Alessandro Iacovelli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

LUCA TONDULLI

Head of Medical Oncology

Provincia autonoma di Bolzano - Alto Adige

ITALY

View details

Stefano Bondi

Candiolo Cancer Institute

ITALY

View details

Laura Deborah Locati

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Paolo Bossi

University of Brescia

ITALY

View details

mattia lauriola

Associate Professor

University of Bologna

ITALY

View details

Stefano Cavalieri

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Carlo Resteghini

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Cristiana Bergamini

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Salvatore Alfieri

Research Interests

Explore related searches

Contact this professor

Articles (20)

The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy

Corrigendum to “Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities” [Transl. Res. 265 (2024) 1-16, (S1931524423001780), (10.1016/j.trsl.2023.10.004)]

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial

Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: Consensus statements from an Italian expert panel

Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers

Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial

Adenoid Cystic carcinoma of minor salivary glands (AdCCmSG): a multidisciplinary update

Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study

HER2-targeted therapies for salivary gland cancers

Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?

Prognostic factors in salvage surgery for recurrent head and neck cancer: A systematic review and meta-analysis.

Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial.

Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.

Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients.

A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of Aqualief<sup>TM</sup> Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia.

Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.

Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib.

Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic.

Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy

The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation.

Collaborators (10)

Lisa Licitra

Nicola Alessandro Iacovelli

LUCA TONDULLI

Stefano Bondi

Laura Deborah Locati

Paolo Bossi

mattia lauriola

Stefano Cavalieri

Carlo Resteghini

Cristiana Bergamini

Make your next move.